Evidence map›Paper›PMID 38929525›Full record

ArticleMedicina (Kaunas, Lithuania)2024

Influence of Dulaglutide on Serum Biomarkers of Atherosclerotic Plaque Instability: An Interventional Analysis of Cytokine Profiles in Diabetic Subjects-A Pilot Study.

Marcin Hachuła, Michał Kosowski, Marcin Basiak, Bogusław Okopień

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marcin HachułaDepartment of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.ORCID 0000-0001-9023-676X
Michał KosowskiDepartment of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.ORCID 0000-0003-2597-463X
Marcin BasiakDepartment of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.ORCID 0000-0003-0674-5612
Bogusław OkopieńDepartment of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.ORCID 0000-0001-7228-2906

Funding

Medical University of Silesia PCN-1-227/N/2/O
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersC-Reactive ProteinCytokinesDiabetes Mellitus, Type 2Glucagon-Like PeptidesHypoglycemic AgentsMatrix Metalloproteinase 9Plaque, AtheroscleroticRecombinant Fusion ProteinsSerum Amyloid P-ComponentAgedAtherosclerosisFemaleGlycopeptidesHumansImmunoglobulin Fc FragmentsBiomarkerscopeptinsC-Reactive ProteinCytokinesdulaglutideGlucagon-Like PeptidesGlycopeptidesHypoglycemic AgentsImmunoglobulin Fc FragmentsLipoprotein(a)Matrix Metalloproteinase 9PentraxinsRecombinant Fusion ProteinsSerum Amyloid P-Componentcopeptindiabetes mellitusdulaglutideGLP-1 receptor agonistlipoprotein(a)MMP-9pentraxin 3semaglutide

Identifiers

PMID38929525
PMCPMC11205508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.